Complaints Outcomes

Search

Search Results

Search Again
Pharmacist Registrant 27 (Feb 11, 2020)

The Inquiry Committee has reinstated pharmacist registrant’s registration which had previously been suspended for an indefinite period on May 12, 2019. Pursuant to Section 32.2(4)(b)(i) of the Health Professions Act, the Inquiry Committee has reached an Agreement with the pharmacist registrant whereby the pharmacist registrant consented to terms including, but not limited to, the following:

  1. To comply with any and all recommendations and treatment prescribed or directed by medical professionals involved in the Registrant's care;
     
  2. To comply with any and all work plans and gradual return to work protocols as advised by the Registrant’s medical professionals and/or employers;
     
  3. To strictly adhere to the Registrant's routine medical monitoring program for the current 3 year period, and then sign an identical agreement for monitoring for an additional 2 years, for a total period of 5 years of monitoring;
     
  4. To not order, handle, prepare, dispense or destroy any narcotic, controlled or targeted substances the Registrant may have access to while being medically monitored;
     
  5. To inform the College in via e-mail of the Registrant’s places of employment as a pharmacist and report any changes to the location of their employment within 48 hours of such change;
     
  6. To inform all managers and employers with whom the Registrant gains employment of the limits and conditions on registration pursuant to the Agreement, if the pharmacy dispenses mood altering drugs;
     
  7. To ensure that all managers and employers with whom the Registrant gains employment submits a written statement to the College declaring their awareness of the limits and conditions on registration pursuant to the Agreement, if the pharmacy dispenses mood altering drugs.

May 12, 2019
(FEBRUARY 11, 2020 - REGISTRATION REINSTATED)

The Inquiry Committee, pursuant to s. 32.2(4)(b)(ii) of the Health Professions Act, has reached an Agreement with the pharmacist registrant to voluntarily suspend the registration as a pharmacist effective May 12, 2019. The Agreement remains in effect until further notice. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.


November 7, 2016

The Inquiry Committee has reinstated pharmacist registrant’s registration which had previously been suspended for an indefinite period on June 10, 2016. The pharmacist registrant’s name has been withheld pursuant to section 39.3(4) of the Health Professions Act


June 10, 2016
(NOVEMBER 7, 2016 – REGISTRATION REINSTATED)

The Inquiry Committee, pursuant to section 36 of the Health Professions Act, has reached an Agreement with the pharmacist registrant to voluntarily suspend the registration as a pharmacist effective June 10, 2016. The Agreement remains in effect until further notice. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to section 39.3(4) of the Health Professions Act.

Deol, Harpreet Singh (Feb 5, 2020)
  1. Nature of Action: ​The Inquiry Committee of the College of Pharmacist of British Columbia (the “College”) conducted an investigation into the practice of Harpreet Deol (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183. The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  2. Effective date: February 5, 2020

  3. Name of registrant: Harpreet Singh Deol​

  4. Location of Practice: Abbotsford, BC

  5. Admissions and Acknowledgements:

    Between February 2018 and August 2019, the Registrant took unauthorized medications for his own personal use from the pharmacy for which he was director and pharmacy manager. The medications taken included, but were not limited to, 11,000 tablets and 116,000 millilitres of narcotic drug substances and 200 tablets and 7 vials of controlled drug substances, both of which require an authorized prescription.

    The Registrant did not process or bill these medications on PharmaNet and these medications were reportedly not provided to any other persons. All narcotic and controlled drug inventory was ordered and managed under the Registrant’s credentials and may have contributed to these losses going undetected.

    A College inspection conducted on August 7th, 2019 identified additional deficiencies in the Registrant’s management of the pharmacy and the pharmacy’s overall practice which included, but were not limited to, inaccurate dispensing of Methadone, inadequate/incomplete documentation, a lack of policies and procedures, inadequate record keeping and management of narcotic inventory, and inadequate pharmacy security

  6. Disposition:

    The Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein the Registrant consented to terms that include (but are not limited to) the following:

    1. To suspend his registration as a pharmacist for a total of 90 days from February 26, 2020 to May 25, 2020;

    2. To not be pharmacy manager, director, or owner of a pharmacy for a period of three years from May 26, 2020 to May 25, 2023;
       
    3. To not be a preceptor or supervisor of pharmacy students or international pharmacy graduates for a period of three years from May 26, 2020 to May 25, 2023;

    4. In relation to narcotic and controlled drugs, to not place and receive orders, destroy expired inventory, or have signing authority relating to the ordering of such substances for a period of three years from May 26, 2020 to May 25, 2023;

    5. To complete and successfully pass an ethics course for healthcare professionals;

    6. To complete and successfully pass training courses pertaining to the provision of Opioid Agonist Treatment (OAT) to patients and the management of a community pharmacy; and

    7. To pay a fine of $2,500.

  7. Rationale:

    The Inquiry Committee considered that in this case, in addition to the serious misconduct, the Registrant placed himself and his patients at significant risk of harm when he took unauthorized medications for personal use and continued to practice in the capacity of a pharmacist. His actions were a serious contravention of standards in the Code of Ethics, and compromised the public’s trust in the pharmacy profession as a whole.

    The Inquiry Committee therefore determined that the Registrant required serious remediation and deterrence regarding his conduct. After also considering significant mitigating factors, the Inquiry Committee considered the terms of the Consent Agreement appropriate to protect the public, as well as send a clear message of deterrence to the profession.

Bao, Leanne Hong Le (Jan 31, 2020)
  1. Nature of Action: ​The Inquiry Committee of the College of Pharmacists of British Columbia (“CPBC”) conducted an investigation into the practice of Leanne Hong Le Bao (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183 (“HPA”).

    The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the HPA.

  2. Effective date: January 31, 2020

  3. Name of registrant: Leanne Hong Le Bao

  4. Location of Practice: Vancouver, BC

  5. Admissions and Acknowledgements:

    The Registrant has admitted and/or acknowledged the following (in part):

    1. The Registrant was in breach of her previous consented undertakings, which can be considered professional misconduct under section 26 of the HPA;
       
    2. The Registrant did not process methadone prescriptions on PharmaNet prior to dispensing on at least 25 occasions, contrary to section 21(1) now section 35(1) of the Pharmacy Operations and Drug Scheduling Act (“PODSA”), Bylaws;

    3. The Registrant did not ensure appropriate documentation and record keeping relating to Methadone Maintenance Treatment practices, contrary to principle 4.1.3 and 2.1.2 of Professional Practice Policy – 66;

    4. As pharmacy manager, the Registrant did not ensure that the pharmacy’s premise was suitable for operation, contrary to section 2(1)(b)(iv) of PODSA prior to April 1, 2018, section 11(2)(c)(d) now section 25(2)(c)(d) of the PODSA, Bylaws and section 8(a) of the Food and Drugs Act
       
  6. Disposition:

    The Registrant entered into a Consent Agreement with the Inquiry Committee of CPBC, wherein the Registrant consented to the following terms (in part): 

    1. To not be a pharmacy manager until:

      • She has completed Jurisprudence Exam;
      • She has completed “The BC Community Pharmacy Manager Training Program” offered by the British Columbia Pharmacy Association; and
      • She has met with the Deputy Registrar to reflect on her conduct and how she will improve her pharmacy practice going forward.
         
    2. To acknowledge a CPBC follow-up inspection may be conducted within a year; and
       
    3. To pay a $5,000.00 fine.​

  7. Rationale:

    The Registrant consented to undertakings in relation to a previous file. The undertakings in the previous file included the College conducting a follow-up inspection. Upon re-inspection, College investigators observed similar deficiencies, including narcotic counts and reconciliations were not completed, Methadone Maintenance Treatment documentation and record keeping were not appropriately completed, and the Pharmacy premise was not suitable for dispensing. Based on this, the Inquiry Committee determined the Registrant’s practice did not comply with the legislated practice standards and that the Registrant was in breach of her previous Consent Agreement, which can be considered as professional misconduct. The Inquiry Committee considered the Registrant’s conduct to be serious and that the Registrant required remediation and a deterrence in order for her practice to come into compliance.

    The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. 

McPherson, Joshua Bruce (Jan 31, 2020)

Nature of Action: Pursuant to section 35(1)(a) of the Health Professions Act, R.S.B.C. 1996, c. 183 (“HPA”), effective January 31, 2020, the Inquiry Committee of the College of Pharmacists of British Columbia has made an order to impose limits and conditions on the pharmacy practice of the registrant Joshua Bruce McPherson (the “Registrant”) during the investigation into the Registrant’s practice.

In addition to restrictions placed on the Registrant’s practice on January 27, 2020 by the Inquiry Committee, the Registrant is restricted from acting as a pharmacy manager as of February 8, 2020.

The Inquiry Committee considered this action necessary to protect the public.

Note: Limits and conditions ordered by the Inquiry Committee under section 35(1)(a) of the HPA are made to protect the public during an investigation or pending a hearing of the Discipline Committee. Orders made under this section relate to matters which are and remain unproven unless admitted by a registrant or determined by the Discipline Committee.


January 27, 2020
(January 31, 2020 - Limits and conditions updated)

Nature of Action: Pursuant to section 35(1)(a) of the Health Professions Act, R.S.B.C. 1996, c. 183 (“HPA”), effective January 27, 2020, the Inquiry Committee of the College of Pharmacists of British Columbia has made an order to impose limits and conditions on the pharmacy practice of the registrant Joshua Bruce McPherson (the “Registrant”) during the investigation into the Registrant’s practice.

The Registrant will be restricted from providing any Opioid Agonist Treatment services as of February 1, 2020.

The Registrant is restricted from providing emergency prescription refills on narcotic, controlled or targeted drugs as well as zopiclone and zolpidem.

The Inquiry Committee considered this action necessary to protect the public.

Reasons: While practicing as a pharmacist, it is alleged that the Registrant did not comply with the applicable legislation and standards of practice required in order to dispense Opioid Agonist Treatment. While practicing as a pharmacist, it is alleged that the Registrant provided emergency prescription refills without exercising appropriate clinical judgement and supporting documentation.

Note: Limits and conditions ordered by the Inquiry Committee under section 35(1)(a) of the HPA are made to protect the public during an investigation or pending a hearing of the Discipline Committee. Orders made under this section relate to matters which are and remain unproven unless admitted by a registrant or determined by the Discipline Committee.

Wiebe, Shaun Ross (Dec 27, 2019)

Nature of Action: Pursuant to section 35(1)(b) of the Health Professions Act R.S.B.C. 1996, c. 183 (“HPA”), the Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) has ordered a suspension of the registration of registrant Shaun Ross Wiebe pending completion of an investigation, unless he provides medical evidence from an addiction medicine specialist, satisfactory to the College, that he is fit to resume practice, or he successfully applies to the Inquiry Committee to cancel the suspension under section 35(4) of the HPA.

The registrant will not be able to practice pharmacy in the province of British Columbia while his registration is suspended.

Effective Date: December 27, 2019

Reasons: The Inquiry Committee was satisfied that there is a prima facie evidence that the registrant suffers from a substance addiction that renders him unfit to practice at this time. The Inquiry Committee was of the view that the registrant’s continued practice poses a risk to the public, and that this risk cannot be addressed at this time with conditions or limits. Therefore, nothing short of suspension at this time will adequately protect the public. 

Pharmacist Registrant 40 (Nov 24, 2019)

The Inquiry Committee has reinstated pharmacist registrant’s registration which had previously be suspended for an indefinite period on May 15, 2019. The pharmacist registrant’s name has been withheld pursuant to section 39.3(4) and (6) of the Health Professions Act.


May 15, 2019
(November 24, 2019 - Registration reinstated)

The Inquiry Committee, pursuant to section 32.2(4)(b)(ii) of the Health Professions Act, has reached an Agreement with the pharmacist registrant to voluntarily suspend the registration as a pharmacist effective May 15, 2019. The Agreement remains in effect until further notice. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacist registrant’s name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.

Pharmacy Technician Registrant 3 (Nov 22, 2019)

The Inquiry Committee has reinstated the pharmacy technician registrant’s registration which had previously been suspended for an indefinite period on September 1, 2018. Pursuant to section 32.2(4)(b)(i) of the Health Professions Act, the Inquiry Committee has reached an Agreement with the pharmacy technician registrant whereby the pharmacy technician registrant consented to terms including, but not limited to, the following:

  1. To comply with any and all recommendations and treatments prescribed or directed by the registrant’s physicians;
     
  2. To comply with every term of a routine medical monitoring program for a minimum of 36 consecutive months;
     
  3. To be restricted from handling, dispensing and packaging narcotics, controlled substances and sedatives, but not to be restricted from to be working in the same area and/or room where medications are stored, supplied and dispensed by other employees; 
     
  4. To be restricted from disposing or dealing with wastage or breakage of or otherwise handle any narcotics, controlled substances and sedatives;
     
  5. To be permanently restricted to working daytime hours with the latest time being 11:00pm on certain days;
     
  6. To ensure all managers and employers, with whom the registrant gains employment, are aware of the registrant’s limits and conditions on the registrant’s registration pursuant to the Agreement;
     
  7. To inform the College of the registrant’s place of employment as a pharmacy technician and report any changes to the location or management within 48 hours of such change; and
     
  8. To comply with the physician’s recommended schedule for a gradual return to work. 

September 1, 2018
(November 22, 2019 - Registration Reinstated)

The Inquiry Committee, pursuant to Section 36 of the Health Professions Act, has reached an agreement with pharmacy technician registrant to suspend her registration as a pharmacy technician for an indefinite period pending further decision of the Inquiry Committee. The Inquiry Committee considers the agreement necessary to protect the public. The registered pharmacy technician registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act.

Pharmacist Registrant 22 (Oct 22, 2019)

The Inquiry Committee has approved an amendment to the June 5, 2019 Consent Agreement. The pharmacist registrant is no longer restricted from being a manager of a pharmacy.


JunE 5, 2019
(October 22, 2018 - LIMITS AND CONDITIONS UPDATED)

The Inquiry Committee, pursuant to section 36(1) of the Health Professions Act and after consultation with the pharmacist registrant’s physician, has reached an Agreement with the pharmacist registrant to amend some of the terms in the Agreement of October 12, 2018. The Registrant can now:

  • work alone in a pharmacy;
  • handle, physically prepare, and dispense prescriptions for opioid medications;
  • have access to the narcotic safe;
  • be involved with ordering narcotic medications.

October 12, 2018
(June 5, 2019 - Limits and Conditions Updated)

The Inquiry Committee has reinstated the pharmacist registrant’s registration which had previously been suspended for an indefinite period on August 13, 2015. Pursuant to Section 36(1) of the Health Professions Act, the Inquiry Committee has reached an Agreement with the pharmacist registrant whereby the pharmacist registrant consented to terms including, but not limited to, the following:

  1. To strictly adhere to the Registrant's routine medical monitoring program with the institution currently involved in the Registrant's care and remaining on the monitoring program for a period of at least 3 years;

  2. To comply with any and all recommendations and treatment prescribed or directed by medical professionals involved in the Registrant's care;

  3. To not work alone in a pharmacy, and to have another pharmacist in good standing supervising the Registrant at all times;

  4. To not handle, physically prepare, or dispense prescriptions for opioid medications at any time;

  5. To not have any access whatsoever, on or off duty, to the narcotic safe in any pharmacy;

  6. To not be involved in any way with ordering narcotic medications, except for signing off on the necessary paperwork in the presence of a witnessing pharmacy staff member for the purposes of receiving and stocking such narcotics;

  7. To inform all managers and employers with whom the Registrant gains employment of his medical condition and the limits and conditions on registration pursuant to the Agreement;

  8. To ensure that all managers and employers with whom the Registrant gains employment submits a written statement to the College declaring their awareness of the Registrant's medical condition and the Agreement, and how they will accommodate and supervise the Registrant working in the pharmacy;
     
  9. To inform the College in via e-mail of his places of employment as a pharmacist and report any changes to the location of his employment within 48 hours of such change; and

  10. To be restricted from acting in the following roles in the Registrant's practice:

    1. Be a manager of a pharmacy;
    2. Be an owner (direct or indirect) of a pharmacy; and
    3. Act as a preceptor.

     


August 13, 2015
(October 12, 2018 – Registration Reinstated)

The Inquiry Committee, pursuant to section 36 of the Health Professions Act, has reached an Agreement with the pharmacist registrant to suspend registration as a pharmacist effective August 13, 2015. The Agreement remains in effect until further notice. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act.


February 13, 2015
(AUGUST 13, 2015 - Registration Suspended)

The Inquiry Committee has reinstated pharmacist registrant’s registration which had previously been suspended for an indefinite period on August 5, 2014. Pursuant to section 36 of the Health Professions Act, the Inquiry Committee has reached an Agreement with the pharmacist registrant whereby the Registrant consented to undertakings involving regular monitoring for fitness to practice pharmacy. The undertakings include, but are not limited to:

  1. Routine and random medical monitoring;

  2. Informing all managers and employers with whom Registrant gains employment of Registrant’s medical condition and the limits and conditions on Registrant’s registration pursuant to the agreement;

  3. Ensuring that all managers and employers with whom Registrant gains employment submits a written statement to the College declaring their awareness of Registrant’s medical condition and the agreement, and how they will accommodate and supervise Registrant working in pharmacy;

  4. Registrant will not work alone in a pharmacy setting, meaning that Registrant must never be the sole pharmacist in attendance at any time and that there must be another pharmacist or pharmacy assistant or pharmacy staff working with Registrant at all times;

  5. Registrant will not have access to narcotic-safe or physically process and/or otherwise prepare any prescriptions that require access to the narcotic safe;

  6. Registrant will not be involved in any way with ordering supplies of narcotic medications;

  7. Registrant will not be involved in the dispensing, ordering, contact, destruction, counting or otherwise handling of opiate medications and other medications with abusive potential;

  8. Being restricted from the following roles in Registrant’s practice:

    1. an owner or manager of a pharmacy;
    2. a director of a corporation that owns a pharmacy; and
    3. a preceptor.

     

  9. Notifying the College of:

    1. all changes in places of employment as a pharmacist
    2. all changes in residential address and phone number; and
    3. all changes in medical provider.

     

The Agreement will remain in place for a minimum of three years of continuous pharmacy practice. The name of the Registrant has been withheld in accordance with section 39.3(4)(a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition. The Inquiry Committee is satisfied that the undertakings will protect the public. 


August 5, 2014
(February 13, 2015 – Registration reinstated)

The Inquiry Committee, pursuant to section 36 of the Health Professions Act, has reached an Agreement with the pharmacist registrant to suspend registration as a pharmacist effective August 5, 2014. The Agreement remains in effect until further notice. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act.

Pharmacist Registrant 14 (Oct 18, 2019)

Pharmacist registrant 14 has satisfied the terms of an Agreement reached with the Inquiry Committee on January 23, 2013. Limits and conditions on the pharmacist registrant’s registration as a pharmacist have now been removed by the Inquiry Committee. The pharmacist registrant’s name has been withheld pursuant to 39.3(4) of the Health Professions Act


January 23, 2013
(October 18, 2019 – Limits and conditions removed) 

The Inquiry Committee has reinstated pharmacist registrant’s registration which was previously suspended for an indefinite period of time on December 10, 2012. Pursuant to Section 36 of the Health Professions Act, the Inquiry Committee has reached an agreement with pharmacist registrant to reinstate his registration to Full Pharmacist subject to certain limits and conditions, effective January 23, 2013. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act.


December 24, 2012
(January 23, 2013 – Registration reinstated) 

The Inquiry Committee, pursuant to Section 36 of the Health Professions Act, has reached an agreement with pharmacist registrant to suspend his registration as a pharmacist for an indefinite period pending further disposition by the Inquiry Committee. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act

Pharmacist Registrant 37 (Oct 15, 2019)

The Inquiry Committee has reinstated pharmacist registrant’s registration which had previously been suspended for an indefinite period on June 25, 2018. Pursuant to section 32.2(4)(b)(i) of the Health Professions Act, the Inquiry Committee has reached an Agreement with the pharmacist registrant whereby the Registrant consented to undertakings. The undertakings include, but are not limited to:

  1. The Registrant will adhere to routine medical monitoring program with the institution currently involved in the Registrant’s case and remain on the program for two years;

  2. In the event of any interruption to the agreed monitoring schedule set out by the medical monitoring program, the Registrant will advise the College of the interruption as soon as possible and provide an explanation for the interruption; and

  3. To comply with any and all recommendations and treatment prescribed or directed by medical professionals involved in the Registrant’s care.  

The Agreement will remain in place until such time as the Registrant’s physician states otherwise. The name of the Registrant has been withheld in accordance with section 39.3(4)(a) of the Health Professions Act for the purpose of not identifying the personal health information of the Registrant. The Inquiry Committee is satisfied that the undertakings will protect the public.


June 25, 2018
(October 15, 2019 – Registration reinstated)

The Inquiry Committee, pursuant to section 36 of the Health Professions Act, has reached an Agreement with pharmacist registrant to suspend registration as a pharmacist for an indefinite period pending further decision of the Inquiry Committee. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act

Pages